Tesamorelin 5mg with reconstitution solution and similar items

Tesamorelin prompts the pituitary to release growth hormone. Tesamorelin is a stabilized analog based on the full 44-amino-acid sequence of growth-hormone-releasing hormone. Its modification makes the peptide more resistant to breakdown. Like other GHRH analogs, it signals the pituitary to make and release the body's own growth hormone in pulses. Growth hormone then raises IGF-1 and acts on fat cells. Visceral fat reduction- The approved and best-evidenced use. In clinical trials, tesamorelin reduced visceral adipose tissue ? the deep abdominal fat associated with metabolic risk ? in the studied population. Body composition- The controlled trial also found changes in waist circumference, waist-to-hip ratio, and patient-rated body image. Off-label users discuss tesamorelin for a smaller waist, lean-mass goals, and more visible muscle definition. Liver-fat researched- A 12-month trial in 61 adults with HIV and nonalcoholic fatty liver disease found a greater reduction in liver fat with tesamorelin than placebo. Recovery and other GH-related goals. Users also discuss tesamorelin for recovery and tissue-repair goals because it raises GH and IGF-1.